Hims & Hers Health, Inc. Class A Common Stock (HIMS) Stock Analysis — Latest Investor Quotes & Trade Calls

Sell Cash Secured Put for HIMS

-1.08%current return

"Beginning with stock number one, which is going to be Hims and Hers Health, stock ticker HIMS. And for those of you that are part of my Options Edge community, you know that this is one I recently fired off an option trade alert to where I sold a cash secured put on this particular stock this week already. At current valuations, although I could see maybe nibbling at the stock here, I would like to buy it at a much lower entry point. And that's where options comes into the equation, allowing me to potentially purchase the stock at a desired price while earning income along the way."

The speaker highlights Hims and Hers Health (HIMS) as a buy candidate via selling cash secured puts to secure a lower entry point. He emphasizes the company’s strong financials and lack of debt while waiting for a more attractive valuation.

Hims & Hers (HIMS): Growth Opportunity Marred by Regulatory Risk

-12.17%current return

"All right. So HIMSS and HERS is really exactly the kind of rule-breaking platform company I look for personally. It's delivering rapid growth, recurring revenue, improving margins, has a relentless expansion into huge new markets."

Sammeet outlines a compelling growth narrative for Hims & Hers (ticker HIMS), noting strong year-over-year growth, recurring revenue streams, and expansion into new areas such as hormonal healthcare. However, subsequent commentary highlights regulatory risks in the hormone business, adding uncertainty to the investment thesis. This insight provides nuanced investor color rather than a direct trade call.